|
The spoligopatterns in cluster and non cluster cases |
|||||
| Spoligopatterns |
Non-cluster cases (n = 193) |
Cluster cases (n = 65) |
|||
|
|
|||||
| Iranian (n = 151) |
Afghanis (n = 42) |
Iranian (n = 48) |
Afghanis (n = 17) |
Total |
|
|
|
|||||
| EAI3 |
39(30.4%) |
12(3.5%) |
4(8.3%) |
3(17.6%) |
58(25.4%) |
| CASI |
19(14.5%) |
12(3.5%) |
10(20.8%) |
0(0%) |
41(17.7%) |
| EAI4 |
26(20.3%) |
3(7.8%) |
2(4.1%) |
1(5.8%) |
32(13.8%) |
| T1 |
26(20.3%) |
2(5.2%) |
3(6.2%) |
0(0%) |
31(13.4%) |
| T2 |
8(6.25%) |
0(0%) |
7(14.5%) |
1(5.8%) |
16(6.9%) |
| Haarlem I |
2(1.5%) |
0(0%) |
12(25%) |
6(35.2%) |
20(8.6%) |
| Beijing |
1(0.78%) |
0(0%) |
7(14.5%) |
4(23%) |
12(5.1%) |
| X1 |
0(0%) |
9(23.6%) |
1(2.0%) |
2(11.7%) |
12(5.1%) |
| CASII |
7(5.4%) |
0(0%) |
2(4.1%) |
0(0%) |
9(3.8%) |
|
|
|||||
| Total |
128 |
38 |
48 |
17 |
231 |
|
|
|||||
| Orphan cases |
23(85.1%) |
4(14.8%) |
0(0%) |
0(0%) |
27 |
Parissa-Farnia et al. BMC Infectious Diseases 2008 8:109 doi:10.1186/1471-2334-8-109 |
|||||